Clinical trial
Cord Blood Expansion on Mesenchymal Stem Cells
NCT00498316 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00498316 |
|---|---|
| Title | Cord Blood Expansion on Mesenchymal Stem Cells |
| Official title | Cord Blood Expansion on Mesenchymal Stem Cells |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | ViaCell Industry National Institutes of Health (NIH) NIH National Cancer Institute (NCI) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndrome, Leukemia |
| Intervention type | Drug, Other, Procedure, Radiation |
| Interventions | Cord Blood Infusion, Busulfan, Fludarabine, Rituximab, ATG, Cyclophosphamide, Clofarabine, Total Body Irradiation (TBI), Melphalan, Tacrolimus and 2 more |
| Enrollment | 98 |
| Start date | Jul 3, 2007 |
| Primary completion | Oct 1, 2016 |
| Completion | Oct 1, 2016 |
| First posted | Jul 10, 2007 |
| Last update posted | Feb 28, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: